Cargando…

Estimating COVID-19 Pneumonia Extent and Severity From Chest Computed Tomography

BACKGROUND: COVID-19 pneumonia extension is assessed by computed tomography (CT) with the ratio between the volume of abnormal pulmonary opacities (PO) and CT-estimated lung volume (CT(LV)). CT-estimated lung weight (CT(LW)) also correlates with pneumonia severity. However, both CT(LV) and CT(LW) de...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Alysson Roncally Silva, Guimarães, Alan, Garcia, Thiego de Souza Oliveira, Madeira Werberich, Gabriel, Ceotto, Victor Fraga, Bozza, Fernando Augusto, Rodrigues, Rosana Souza, Pinto, Joana Sofia F., Schmitt, Willian Rebouças, Zin, Walter Araujo, França, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917083/
https://www.ncbi.nlm.nih.gov/pubmed/33658944
http://dx.doi.org/10.3389/fphys.2021.617657
Descripción
Sumario:BACKGROUND: COVID-19 pneumonia extension is assessed by computed tomography (CT) with the ratio between the volume of abnormal pulmonary opacities (PO) and CT-estimated lung volume (CT(LV)). CT-estimated lung weight (CT(LW)) also correlates with pneumonia severity. However, both CT(LV) and CT(LW) depend on demographic and anthropometric variables. PURPOSES: To estimate the extent and severity of COVID-19 pneumonia adjusting the volume and weight of abnormal PO to the predicted CT(LV) (pCT(LV)) and CT(LW) (pCT(LW)), respectively, and to evaluate their possible association with clinical and radiological outcomes. METHODS: Chest CT from 103 COVID-19 and 86 healthy subjects were examined retrospectively. In controls, predictive equations for estimating pCT(LV) and pCT(LW) were assessed. COVID-19 pneumonia extent and severity were then defined as the ratio between the volume and the weight of abnormal PO expressed as a percentage of the pCT(LV) and pCT(LW), respectively. A ROC analysis was used to test differential diagnosis ability of the proposed method in COVID-19 and controls. The degree of pneumonia extent and severity was assessed with Z-scores relative to the average volume and weight of PO in controls. Accordingly, COVID-19 patients were classified as with limited, moderate and diffuse pneumonia extent and as with mild, moderate and severe pneumonia severity. RESULTS: In controls, CT(LV) could be predicted by sex and height (adjusted R(2) = 0.57; P < 0.001) while CT(LW) by age, sex, and height (adjusted R(2) = 0.6; P < 0.001). The cutoff of 20% (AUC = 0.91, 95%CI 0.88–0.93) for pneumonia extent and of 50% (AUC = 0.91, 95%CI 0.89–0.92) for pneumonia severity were obtained. Pneumonia extent were better correlated when expressed as a percentage of the pCT(LV) and pCT(LW) (r = 0.85, P < 0.001), respectively. COVID-19 patients with diffuse and severe pneumonia at admission presented significantly higher CRP concentration, intra-hospital mortality, ICU stay and ventilatory support necessity, than those with moderate and limited/mild pneumonia. Moreover, pneumonia severity, but not extent, was positively and moderately correlated with age (r = 0.46) and CRP concentration (r = 0.44). CONCLUSION: The proposed estimation of COVID-19 pneumonia extent and severity might be useful for clinical and radiological patient stratification.